Literature DB >> 2672168

[Use of an inhibition method of ELISA in the serologic diagnosis of dengue. Preliminary report].

S Vázquez Ramudo, R Fernández Llanes.   

Abstract

This paper reports the standardization of an ELISA (enzyme-linked immunosorbent assay) inhibition method for the serologic diagnosis of dengue, with the use of non-purified antigen. The conditions and criteria of the test for detection of antibodies for a group of 82 sera (12 monosera and 35 paired sera) are established. The results are compared with those obtained by hemagglutination inhibition and a good agreement between the two tests, as well as greater sensitivity of ELISA, is found. Some advantages of this technique in connection with hemagglutination inhibition are listed; they are: easy performance, rapidity, no need for serum treatment, and the use of viral suspensions without using any method of extraction.

Mesh:

Substances:

Year:  1989        PMID: 2672168

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  4 in total

1.  Diagnosis of dengue virus infection by the visual and simple AuBioDOT immunoglobulin M capture system.

Authors:  Susana Vázquez; Gilda Lemos; Maritza Pupo; Oscar Ganzón; Daniel Palenzuela; Adriana Indart; María G Guzmán
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

Review 2.  Advances in dengue diagnosis.

Authors:  M G Guzmán; G Kourí
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

3.  Antibody-dependent enhancement of severe dengue disease in humans.

Authors:  Leah C Katzelnick; Lionel Gresh; M Elizabeth Halloran; Juan Carlos Mercado; Guillermina Kuan; Aubree Gordon; Angel Balmaseda; Eva Harris
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

4.  Development of in-house serological methods for diagnosis and surveillance of chikungunya.

Authors:  Saira Saborío Galo; Karla González; Yolanda Téllez; Nadezna García; Leonel Pérez; Lionel Gresh; Eva Harris; Ángel Balmaseda
Journal:  Rev Panam Salud Publica       Date:  2017-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.